|
English
|
正體中文
|
简体中文
|
2822924
|
|
???header.visitor??? :
30008736
???header.onlineuser??? :
1054
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"liu wei ni"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
國立交通大學 |
2018-08-21T05:53:35Z |
CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer
|
Huang, Li-Chi; Tam, Ka-Wai; Liu, Wei-Ni; Lin, Chun-Yu; Hsu, Kai-Wen; Hsieh, Wen-Shyang; Chi, Wei-Ming; Lee, Ai-Wei; Yang, Jinn-Moon; Lin, Ching-Ling; Lee, Chia-Hwa |
臺北醫學大學 |
2018 |
Development of novel therapeutic target of growth factor receptors in anaplastic thyroid cancer
|
劉韋妮; Liu, Wei-Ni |
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
|